How Crestwood Capital Management, L.P. Shifted its Portfolio in Q3 2022 and Q4 2022
Ava Hoppe | 24 April, 2023
Crestwood Capital Management, L.P. is a renowned investment management firm established in 2001 that primarily focuses on equity investments in healthcare, technology, and consumer sectors. Managed by John Leonard and David Mortman, Crestwood noted significant changes in its holdings between Q3-2022 and Q4-2022. In this blog, we'll explore how Crestwood Capital Management altered its positions in leading companies and its impact on the firm's overall portfolio.
Crestwood Capital Management's Q3-2022 Portfolio Holdings
During Q3-2022, Crestwood Capital Management held 14 stocks in its portfolio. The top holdings of the firm during this period were in Progyny Inc (PGNY), ICICI Bank Ltd (IBN), H World Group Ltd (0A2I.IL), and Advanced Micro Devices Inc (AMD). Crestwood Capital Management's holdings in PGNY rose by 23.3% from 455,636 shares to 563,932 shares worth $17,566,000. Simultaneously, IBN's holdings decreased by 8.5% from 816,569 shares to 747,195 shares valued at $16,356,000. However, H World Group Ltd's holdings increased by 27.4% from 362,193 shares to 364,738 shares worth $15,472,000.
Crestwood Capital Management's Q4-2022 Portfolio Holdings
During Q4-2022, Crestwood Capital Management decreased its holdings in most stocks and held investments in only ten companies. The leading holdings of the firm during this period were in Progyny Inc (PGNY), Toast Inc (TOST), and Advanced Micro Devices Inc (AMD). The firm increased its holdings in PGNY by 23.3% from 455,636 shares to 563,932 shares worth $17,566,000. TOST was a new addition to the firm's portfolio in Q4-2022, with holdings of 366,562 shares valued at $6,609,000.
Crestwood Capital Management's Notable Changes in Q3 2022 and Q4 2022
Crestwood Capital Management decreased its holdings in some prominent stocks, including Xometry Inc (XMTR), Carvana Co (CVNA), and Ferrari N.V. (RACE). CVNA was entirely eliminated from the firm's portfolio, whereas Xometry Inc's holdings decreased by 23.6% from 284,894 shares to 219,298 shares worth $7,067,000. In contrast, RACE's holdings reduced by a massive 61.8% from 26,131 shares to 8,631 shares valued at $1,848,000.
Furthermore, Crestwood Capital Management acquired new holdings in DoubleVerify Hldgs Inc (DV) and The RealReal Inc (REAL) during Q4-2022. The holdings in DV were 189,219 shares worth $4,155,000, whereas the holdings in REAL were 1,389,960 shares valued at $1,737,000.
Conclusion
During Q3-2022 and Q4-2022, Crestwood Capital Management, L.P. made some significant changes to its portfolio, acquiring new holdings in some companies and decreasing its holdings in others. The firm's position in its top holdings, including PGNY, IBN, AMD, and TOST, added stability to its portfolio. Crestwood Capital Management's moves in DV and REAL might pay off due to their potential for future growth. It will be interesting to track the firm's activities in the coming years and see how it shifts its portfolio to adapt to market changes.
Other Posts
- Intrinsic Edge Capital Management LLC Q3 2022 vs. Q4 2022: A Look into Their Top Holdings
- An In-depth Look at Weiss Multi-Strategy Advisers LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Investment Insights: Providence Wealth Advisors, LLC Q3 2022 vs. Q4 2022 Holdings Comparison
- Investment Insights: Tanaka Capital Management's Q3 2022 vs. Q4 2022 holdings comparison
- Port Capital LLC Q3 2022 vs. Q4 2022 13F Holdings: Which Stocks Were On the Rise and Which Ones Fell?
- American Trust Investment Advisors, LLC Q3 2022 vs. Q4 2022: Fund Holdings Comparison
- Analyzing Hahn Capital Management LLC's Q4 2022 vs. Q1 2023 13F Holdings Comparison
- Bridgeworth, LLC's Q4 2022 vs. Q1 2023 Holdings Comparison: Top Winners and Losers Revealed
- Changes in Krane Funds Advisors LLC Q3 2022 vs. Q4 2022 13F Holdings
- SurgNet Health Partners, Inc. Revolutionizing ASC Development and Management